Psychoactive Medicines Law Team
Harry works with clients in the psychoactive medicines and cannabis sectors, providing advice on regulatory and commercial matters.
His previous experience in market-leading firms such as Freshfields Bruckhaus Deringer means that he is used to dealing with the most complex and demanding mandates. Harry made the switch to focus on the legal space around plant and psychoactive medicines because of his desire to help clients at the forefront of tackling the modern mental health epidemic. Clients value his personable manner and practical, commercial advice.
Outside of his work as a solicitor, Harry volunteers with a number of harm reduction and evidence-based drugs reform organisations, including the PAR campaign, PsyCare UK and Breaking Convention.